Assembly Bill 555 would cap the out-of-pocket cost for insulin at $35 for a 30-day supply for people insured with private health insurance. Right now, that limit is just for Medicare recipients.
During the hearing, Democratic Assembly Speaker Steve Yeager said some Nevadans pay up to $500 per month for insulin.
“Through this legislation, we’d be lowering costs for Nevadans, making sure they don’t have to choose between necessary life-saving medicine and basic necessities such as groceries, gas or utilities,” Yeager said.
Americans for Prosperity-Nevada opposed the bill, stating that price control could reduce competition, disrupt supply and increase cost elsewhere to offset the change.
Twenty-six other states have limits on insulin copays under commercial insurance, ranging from zero to $100 a month.
The Nevada Division of Insurance estimates 70,000 Nevadans could be directly impacted by this bill.
